DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)



company name or ticker

Why ZIOPHARM (ZIOP) is Poised to Beat Earnings Estimates? - Tale of the Tape

Surging Earnings Estimates Signal Good News for ZIOPHARM (ZIOP) - Tale of the Tape

Why ZIOPHARM Oncology, Inc. Zoomed Today

Is this meaningful or just another movement?

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind

Myraid Genetics, Sarepta Therapeutics, Questcor Pharmaceuticals, Ziopharm Oncology, and MannKind top the list of the most shorted biotechs.

4 Stocks Under $10 Making Big Moves

CytRx Directors Are $3M Richer With Well-Timed Stock Option Grants

ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Mel

ZIOPHARM Announces Positive Phase 1/2 Interim Results for Ad-RTS-IL-12 in Patients With Advanced Melanoma

ZIOPHARM Announces Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/

ZIOPHARM Announces Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12

Sector Update: Healthcare Stocks Higher; Ziopharm Climbs 5% on Approval for Study of Brain Cancer

Sector Update: Healthcare

See More Articles...